| Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, SW Behrman, AB Benson, ... Journal of the National Comprehensive Cancer Network 19 (4), 439-457, 2021 | 699 | 2021 |
| NCCN guidelines insights: soft tissue sarcoma, version 1.2021: featured updates to the NCCN guidelines M von Mehren, JM Kane, MM Bui, E Choy, M Connelly, S Dry, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 18 (12), 1604-1612, 2020 | 219 | 2020 |
| Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease VG Giby, TA Ajith World journal of hepatology 6 (8), 570, 2014 | 142 | 2014 |
| NCCN guidelines® insights: older adult oncology, version 1.2021: featured updates to the NCCN guidelines E Dotan, LC Walter, IS Browner, K Clifton, HJ Cohen, M Extermann, ... Journal of the National Comprehensive Cancer Network 19 (9), 1006-1019, 2021 | 94 | 2021 |
| Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers BM Huffman, VN Aushev, GL Budde, J Chao, F Dayyani, D Hanna, ... JCO Precision Oncology 6, e2200420, 2022 | 28 | 2022 |
| Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer JY Hou, JS Chapman, E Kalashnikova, W Pierson, K Smith-McCune, ... Gynecologic Oncology 167 (2), 334-341, 2022 | 22 | 2022 |
| Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. GP Botta, M Abdelrahim, VN Aushev, A Esmail, B Drummond, S Sharma, ... Journal of Clinical Oncology 40 (4_suppl), 517-517, 2022 | 7 | 2022 |
| Soft tissue sarcoma, version 1.2021: featured updates to the NCCN guidelines M von Mehren, JM Kane, MM Bui, E Choy, M Connelly, S Dry, KN Ganjoo, ... JNCCN Journal of the National Comprehensive Cancer Network 18 (12), 1605-1612, 2020 | 6 | 2020 |
| Older adult oncology, version 1.2021: Featured updates to the NCCN guidelines E Dotan, LC Walter, IS Browner, K Clifton, HJ Cohen, M Extermann, ... JNCCN Journal of the National Comprehensive Cancer Network 19 (9), 1006-1019, 2021 | 3 | 2021 |
| Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma M Zhou, N Bui, R Rathore, S Sudhaman, GV George, AK Malashevich, ... Cancers 15 (1), 157, 2022 | 2 | 2022 |
| Role of Circulating Tumor DNA As a Prognostic Biomarker in Patients with Diffuse Large B-Cell Lymphoma MS Narkhede, S Tomassetti, M Iqbal, A Tin, S Rivero-Hinojosa, ... Blood 142, 4376, 2023 | 1 | 2023 |
| 590P Assessment of circulating tumor (ct) DNA in patients (pts) with locally advanced rectal cancer (LARC) pts treated with neoadjuvant therapy (NAT) C Molinari, G Marisi, G Laliotis, E Spickard, IG Rapposelli, E Petracci, ... Annals of Oncology 34, S428, 2023 | 1 | 2023 |
| The Ethics of Medical Involvement in Lethal Injection Executions: Discussing the Role of the Anesthesia Provider. G George, J Stanford Penn Bioethics Journal 7 (1), 2011 | 1 | 2011 |
| Resolving Discrepancies in Idylla BRAF Mutational Assay Results Using Targeted Next-Generation Sequencing GV George, H Liu, AN Jajosky, ZN Oltvai Genes 15 (5), 527, 2024 | | 2024 |
| ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma GV George, DS Wallace, Y Wang, J Carney, M Elsadawi, WR Burack, ... Histopathology 84 (5), 900-902, 2024 | | 2024 |
| Gamma-delta T-cell acute lymphoblastic lymphoma/leukemia: a report of a rare entity GV George, M Kajstura, AG Evans, CR Syposs Journal of Hematopathology, 1-5, 2024 | | 2024 |
| Case Series of BRAF V600E-Mutant Acute Myeloid Leukemia (AML): A Possible Lethal Molecular Subgroup G George, M Elsadawi, S Okutan, J Fitzsimmons, A Evans, A Jajosky JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S43-S44, 2023 | | 2023 |
| Efficient Lung Cancer Molecular Diagnostics by Combining Next Generation Sequencing with Reflex Idylla Genefusion Assay Testing D Nkosi, GV George, H Liu, M Buldo, MJ Velez, ZN Oltvai Genes 14 (8), 1551, 2023 | | 2023 |
| Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers. D Hanna, G Botta, D Catenacci, S Maron, S Krinshpun, S Sharma, ... | | 2022 |
| ctDNA in treatment response monitoring in patients with relapsed gynecologic malignancies. JR Williams, K Grzankowski, K Castaneda, JS Saldivar, C Diaz-Arrastia, ... Journal of Clinical Oncology 40 (16), E17501-E17501, 2022 | | 2022 |
Siba El Hussein MDMD Anderson Cancer CenterVerified email at mdanderson.org
